241 related articles for article (PubMed ID: 29110584)
1. MicroRNA-target cross-talks: Key players in glioblastoma multiforme.
Toraih EA; Aly NM; Abdallah HY; Al-Qahtani SA; Shaalan AA; Hussein MH; Fawzy MS
Tumour Biol; 2017 Nov; 39(11):1010428317726842. PubMed ID: 29110584
[TBL] [Abstract][Full Text] [Related]
2. Estimating survival time of patients with glioblastoma multiforme and characterization of the identified microRNA signatures.
Yerukala Sathipati S; Huang HL; Ho SY
BMC Genomics; 2016 Dec; 17(Suppl 13):1022. PubMed ID: 28155650
[TBL] [Abstract][Full Text] [Related]
3. A restricted signature of serum miRNAs distinguishes glioblastoma from lower grade gliomas.
Regazzo G; Terrenato I; Spagnuolo M; Carosi M; Cognetti G; Cicchillitti L; Sperati F; Villani V; Carapella C; Piaggio G; Pelosi A; Rizzo MG
J Exp Clin Cancer Res; 2016 Jul; 35(1):124. PubMed ID: 27476114
[TBL] [Abstract][Full Text] [Related]
4. A 4-miRNA signature to predict survival in glioblastomas.
Hermansen SK; Sørensen MD; Hansen A; Knudsen S; Alvarado AG; Lathia JD; Kristensen BW
PLoS One; 2017; 12(11):e0188090. PubMed ID: 29136645
[TBL] [Abstract][Full Text] [Related]
5. MicroRNA-149 is epigenetically silenced tumor-suppressive microRNA, involved in cell proliferation and downregulation of AKT1 and cyclin D1 in human glioblastoma multiforme.
Ghasemi A; Fallah S; Ansari M
Biochem Cell Biol; 2016 Dec; 94(6):569-576. PubMed ID: 27783537
[TBL] [Abstract][Full Text] [Related]
6. A five-miRNA signature with prognostic and predictive value for MGMT promoter-methylated glioblastoma patients.
Cheng W; Ren X; Cai J; Zhang C; Li M; Wang K; Liu Y; Han S; Wu A
Oncotarget; 2015 Oct; 6(30):29285-95. PubMed ID: 26320189
[TBL] [Abstract][Full Text] [Related]
7. MicroRNA-34a: A Key Regulator in the Hallmarks of Renal Cell Carcinoma.
Toraih EA; Ibrahiem AT; Fawzy MS; Hussein MH; Al-Qahtani SAM; Shaalan AAM
Oxid Med Cell Longev; 2017; 2017():3269379. PubMed ID: 29104726
[TBL] [Abstract][Full Text] [Related]
8. A microRNA signature profile in EBV+ diffuse large B-cell lymphoma of the elderly.
Andrade TA; Evangelista AF; Campos AH; Poles WA; Borges NM; Camillo CM; Soares FA; Vassallo J; Paes RP; Zerbini MC; Scapulatempo C; Alves AC; Young KH; Colleoni GW
Oncotarget; 2014 Dec; 5(23):11813-26. PubMed ID: 25544772
[TBL] [Abstract][Full Text] [Related]
9. Relationship between magnetic resonance imaging features and miRNA gene expression in patients with glioblastoma multiforme.
Li WB; Chen HY; Zhang W; Yan W; Shi R; Li SW; Jiang T
Chin Med J (Engl); 2013; 126(15):2881-5. PubMed ID: 23924460
[TBL] [Abstract][Full Text] [Related]
10. Longevity-Related Gene Transcriptomic Signature in Glioblastoma Multiforme.
Fawzy MS; Badran DI; Al Ageeli E; Al-Qahtani SAM; Alghamdi SA; Helal GM; Toraih EA
Oxid Med Cell Longev; 2018; 2018():8753063. PubMed ID: 29849920
[TBL] [Abstract][Full Text] [Related]
11. Downregulation of serum microRNA-205 as a potential diagnostic and prognostic biomarker for human glioma.
Yue X; Lan F; Hu M; Pan Q; Wang Q; Wang J
J Neurosurg; 2016 Jan; 124(1):122-8. PubMed ID: 26230475
[TBL] [Abstract][Full Text] [Related]
12. A 4-MicroRNA signature can discriminate primary lymphomas from anaplastic carcinomas in thyroid cytology smears.
Fassina A; Cappellesso R; Simonato F; Siri M; Ventura L; Tosato F; Busund LT; Pelizzo MR; Fassan M
Cancer Cytopathol; 2014 Apr; 122(4):274-81. PubMed ID: 24327568
[TBL] [Abstract][Full Text] [Related]
13. Low serum level of miR-485-3p predicts poor survival in patients with glioblastoma.
Wang ZQ; Zhang MY; Deng ML; Weng NQ; Wang HY; Wu SX
PLoS One; 2017; 12(9):e0184969. PubMed ID: 28931080
[TBL] [Abstract][Full Text] [Related]
14. Serum microRNA microarray analysis identifies miR-4429 and miR-4689 are potential diagnostic biomarkers for biliary atresia.
Dong R; Shen Z; Zheng C; Chen G; Zheng S
Sci Rep; 2016 Feb; 6():21084. PubMed ID: 26879603
[TBL] [Abstract][Full Text] [Related]
15. hsa-miR-9 controls the mobility behavior of glioblastoma cells via regulation of MAPK14 signaling elements.
Ben-Hamo R; Zilberberg A; Cohen H; Efroni S
Oncotarget; 2016 Apr; 7(17):23170-81. PubMed ID: 27036038
[TBL] [Abstract][Full Text] [Related]
16. Circulating microRNAs as biomarkers of adult Crohn's disease.
Jensen MD; Andersen RF; Christensen H; Nathan T; Kjeldsen J; Madsen JS
Eur J Gastroenterol Hepatol; 2015 Sep; 27(9):1038-44. PubMed ID: 26230660
[TBL] [Abstract][Full Text] [Related]
17. A three-microRNA signature identifies two subtypes of glioblastoma patients with different clinical outcomes.
Marziali G; Buccarelli M; Giuliani A; Ilari R; Grande S; Palma A; D'Alessandris QG; Martini M; Biffoni M; Pallini R; Ricci-Vitiani L
Mol Oncol; 2017 Sep; 11(9):1115-1129. PubMed ID: 28248456
[TBL] [Abstract][Full Text] [Related]
18. Diagnostic and prognostic implications of microRNA profiling in prostate carcinoma.
Schaefer A; Jung M; Mollenkopf HJ; Wagner I; Stephan C; Jentzmik F; Miller K; Lein M; Kristiansen G; Jung K
Int J Cancer; 2010 Mar; 126(5):1166-76. PubMed ID: 19676045
[TBL] [Abstract][Full Text] [Related]
19. miR-130a can predict response to temozolomide in patients with glioblastoma multiforme, independently of O6-methylguanine-DNA methyltransferase.
Chen H; Li X; Li W; Zheng H
J Transl Med; 2015 Feb; 13():69. PubMed ID: 25890369
[TBL] [Abstract][Full Text] [Related]
20. Primate-specific miR-663 functions as a tumor suppressor by targeting PIK3CD and predicts the prognosis of human glioblastoma.
Shi Y; Chen C; Zhang X; Liu Q; Xu JL; Zhang HR; Yao XH; Jiang T; He ZC; Ren Y; Cui W; Xu C; Liu L; Cui YH; Yu SZ; Ping YF; Bian XW
Clin Cancer Res; 2014 Apr; 20(7):1803-13. PubMed ID: 24523440
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
